“…BPXV resembles VACV in terms of its properties (size, shape, structure, and physicochemical properties) [ 156 ], pathogenesis, and pathology. Phylogenetic analyses confirmed the monophyly of the BPXV and its likely origin from the VACV Lister vaccine [ 155 , 156 , 157 , 158 , 159 ]. Since its first description, outbreaks of BPXV have been reported in India, Pakistan, Nepal, Egypt, Bangladesh, Indonesia, Russia, and Italy [ 15 , 43 , 53 , 160 , 161 , 162 ].…”